Cure8 research brief
Dysplasia is the key premalignant change that raises colorectal cancer risk in people with colonic IBD. Better detection and clearer management pathways can reduce cancer risk and help patients avoid unnecessary surgery.
Adults with long-standing colonic ulcerative colitis or Crohn's disease with colonic involvement, gastroenterologists and colorectal surgeons, pathologists, and researchers studying IBD-associated carcinogenesis or surveillance strategies.
This review summarizes current thinking on the biology of dysplasia in IBD, describing inflammation-driven pathways (genetic, epigenetic, metabolic, and immune changes) that create a field effect and multifocal lesions. It emphasizes histological classification challenges and the need for expert pathology review.
The article discusses contemporary detection strategies, including high-quality colonoscopy, chromoendoscopy, and advanced imaging to improve lesion recognition, plus contemporary endoscopic resection techniques and criteria for recommending colectomy. It also covers individualized post-resection surveillance planning.
Takeaway points: multidisciplinary care (expert endoscopy, pathology, and individualized decision-making) is central to managing dysplasia in IBD; improved diagnostic modalities and risk stratification are active areas of research.
Structured content depth: abstract — the brief is grounded in the source-provided abstract (review article). This is a review summarizing existing evidence rather than reporting new trial results.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Elevated pancreatic enzymes are relatively common in IBD and can reflect very different conditions (benign asymptomatic elevations, pancreatitis variants, or autoimmune pancreatitis). Recognizing phenotype-specific...
The study will prospectively evaluate how often dysplasia occurs, how lesions look and behave after endoscopic resection, and what factors predict local or distant recurrence—information that could change surveillance...
People with celiac disease may have higher risks for several digestive cancers and for inflammatory bowel diseases (Crohn’s and UC) according to this large French cohort study. Knowing these associations can help...
